Achieve Life Sciences ACHV Cash Flow Statement (2010-2026)

NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Achieve Life Sciences Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Achieve Life Sciences reported cash from operations of -$10.78M and free cash flow of -$10.78M for the quarter ended Jun 2026, down 18.4% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
Share-based Compensation
0.53M0.49M0.82M0.84M0.83M0.78M1.33M1.46M1.46M-0.01M1.93M1.93M1.93M1.24M2.26M2.89M2.34M1.30M9.10M16.80M
Deferred Taxes
Gains from Investment Securities
0.05M0.06M0.06M0.45M0.09M0.10M0.11M0.11M-0.28M48.53M
Asset Writedowns and Impairment
Cash from Restructuring
Change in Interest Receivables
Cash from Operations
-8.69M-5.22M-6.78M-8.34M-11.31M-11.14M-8.30M-6.68M-5.14M-4.36M-5.29M-4.92M-10.39M-9.17M-11.10M-9.10M-11.30M-18.00M-6.93M-10.78M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges
0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF)Depreciation & Amortization
0.06M0.06M0.06M0.06M0.06M0.07M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.05M0.06M0.06M0.06M
Change in Working Capital
Change in Receivables
Change in Account Payables
0.24M0.03M-0.42M0.24M-0.24M1.23M-0.60M-0.70M0.28M-0.02M-0.24M0.18M0.46M0.94M-0.29M-0.44M0.72M-1.08M-0.05M-0.20M
Change in Accured Expenses
0.29M0.86M-1.28M0.44M0.29M0.29M-0.93M0.49M0.75M0.32M-1.45M0.48M1.51M0.17M-2.06M0.60M2.69M-2.34M0.26M0.76M
Other Working Capital Changes
0.85M0.08M0.01M0.09M1.16M-0.33M-0.89M-0.63M0.90M-0.56M-0.09M0.03M1.60M-0.77M-0.09M-0.51M0.46M1.34M-1.62M-0.92M
Investing Activities
Capital Expenditures
0.01M
Sales of Property, Plant and Equipment
Change in Acquisitions & Divestments
12.65M14.72M7.60M2.75M5.80M15.43M1.20M
Cash from Investing Activities
-0.01M13.27M11.72M11.35M6.70M-12.65M0.71M14.28M-137.80M
Financing Activities
Other financing activities
0.01M-0.00M0.02M0.10M0.08M0.15M56.11M-0.04M-55.89M0.50M0.12M1.26M0.02M0.14M
Debt Issuance and Repayment
Long-Term Debt Issuances
Short-Term Debt issuances
0.09M1.41M-0.17M
Change in Capital Stock
Shares Issued
9.45M9.45M9.47M9.68M9.71M17.90M17.93M21.11M21.17M21.17M34.25M34.34M34.39M34.69M53.23M
Net Shares Issued and Repurchased
0.29M0.27M0.30M0.51M0.64M0.47M0.68M0.12M0.93M2.31M11.71M
Net Equity Issued and Repurchased
Misc.
Cash from Financing Activities
0.01M14.93M0.10M1.38M0.13M17.71M0.05M15.23M56.11M-0.15M-8.11M0.68M4.04M6.26M0.02M168.46M
Exchange Rate Effect
-0.00M-0.00M0.00M-0.00M0.00M-0.00M0.00M
Change in Cash
-8.69M9.71M-6.68M-6.96M-11.18M6.57M-8.26M8.56M-5.15M-4.37M50.82M-51.64M-5.21M3.21M0.26M38.86M-19.94M-11.00M7.36M19.88M
Free Cash Flow
-8.69M-5.22M-6.78M-8.34M-11.31M-11.14M-8.30M-6.68M-5.14M-4.37M-5.29M-4.92M-10.39M-9.17M-11.10M-9.10M-11.30M-18.00M-6.93M-10.78M
Net Cash Flow
-8.69M9.71M-6.68M-6.96M-11.18M6.57M-8.26M8.55M-5.14M-4.37M50.82M-5.07M-5.23M3.23M0.25M-2.40M-19.91M-11.03M7.37M19.88M